BHARAT MEHTA: Open Payments
NPI 1033104484 · EASTON, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,538 in 86 payments from 15 companies in 2025. Trend: 2023 $3,831 · 2024 $2,501 · 2025 $3,538
Food & beverage: $3,447Education: $91
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 16 | $603 |
| Novo Nordisk Inc | 11 | $598 |
| AstraZeneca Pharmaceuticals LP | 10 | $480 |
| Teva Pharmaceuticals USA, Inc. | 7 | $401 |
| Bayer Healthcare Pharmaceuticals Inc. | 7 | $306 |
| Neurocrine BioSciences, Inc. | 7 | $251 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $196 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $165 |
| SK Life Science, Inc. | 4 | $163 |
| Amgen Inc. | 3 | $148 |
Products named: MOUNJARO, AUSTEDO XR, Kerendia, Ozempic, ZEPBOUND, INGREZZA, Wegovy, JARDIANCE.
Industry payments across PA — which companies pay providers there.
